肝细胞癌局部消融治疗:肿瘤大小、位置与生物学特征的临床意义
本综述聚焦3 cm以下肝细胞癌的局部消融治疗,阐述肿瘤大小、位置和生物学特征对治疗决策的临床意义。肿瘤越大局部控制越差;无接触射频消融较常规射频消融局部控制更优;冷冻消融在血管胆管旁并发症更少。MRI表现和血清标志物可预测微血管侵犯等侵袭性生物学。
要点
- 肿瘤越大局部控制越差,与消融边缘不足及微血管侵犯、卫星结节风险相关。
- 无接触射频消融较常规射频消融局部控制更优,对肝顶病灶或有侵袭性生物学者尤有前景。
- 腹腔镜射频消融适用于前膈下肝细胞癌,人工胸水辅助射频消融可控制后膈下肝细胞癌。
核心结论
- 全面理解肿瘤大小、位置和生物学特征对优化肝细胞癌局部消融治疗的获益至关重要。
- 无接触射频消融通过获得足够消融边缘,较常规射频消融显示出更优的局部肿瘤控制。
- 门静脉周围肝细胞癌手术切除的生存结局通常优于射频消融。
- 冷冻消融在血管或胆管旁肝细胞癌中血管或胆道并发症发生率低于射频消融。
研究设计与样本
- 综述,聚焦3 cm以下肝细胞癌局部消融(射频消融、微波消融、冷冻消融)的临床意义。
- 原文未报告系统检索范围与纳入文献数量。
关键影像表现/征象
- 较大肿瘤因难以形成足够消融边缘及可能存在微血管侵犯和瘤周卫星结节,局部肿瘤控制较差。
- 侵袭性肝细胞癌亚型在MRI上常表现为肝脏影像报告和数据系统M特征,有助于判断预后。
- 微血管侵犯等侵袭性生物学可通过MRI表现和血清肿瘤标志物预测。
临床应用与阅片要点
- 无接触射频消融较常规射频消融局部肿瘤控制更优,对肝顶病灶或侵袭性生物学肿瘤尤其有前景。
- 腹腔镜射频消融对前膈下肝细胞癌有益,人工胸水辅助射频消融对控制后膈下肝细胞癌有效。
- 门静脉周围肝细胞癌手术切除的生存结局通常优于射频消融。
- 血管或胆管旁肝细胞癌冷冻消融的血管或胆道并发症发生率低于射频消融。
- MRI的肝脏影像报告和数据系统M特征及血清肿瘤标志物可用于预测侵袭性生物学和判断预后。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Local ablation therapy, encompassing radiofrequency ablation (RFA), microwave ablation, and cryoablation, has emerged as a crucial strategy for managing small hepatocellular carcinomas (HCCs), complementing liver resection and transplantation. This review delves into the clinical significance of tumor size, location, and biology in guiding treatment decisions for HCCs undergoing local ablation therapy, with a focus on tumors smaller than 3 cm. Tumor size significantly influences treatment outcomes, with larger tumors associated with poorer local tumor control due to challenges in creating sufficient ablative margins and the likelihood of microvascular invasion and peritumoral satellite nodules. Advanced ablation techniques such as centripetal or no-touch RFA using multiple electrodes, cryoablation using multiple cryoprobes, and microwave ablation offer diverse options for HCC treatment. Notably, no-touch RFA demonstrates superior local tumor control compared with conventional RFA by achieving sufficient ablative margins, making it particularly promising for hepatic dome lesions or tumors with aggressive biology. Laparoscopic RFA proves beneficial for treating anterior subphrenic HCCs, whereas artificial pleural effusion-assisted RFA is effective for controlling posterior subphrenic HCCs. However, surgical resection generally offers better survival outcomes for periportal HCCs compared with RFA. Cryoablation exhibits a lower incidence of vascular or biliary complications than RFA for HCCs adjacent to perivascular or periductal regions. Additionally, aggressive tumor biology, such as microvascular invasion, can be predicted using magnetic resonance imaging findings and serum tumor markers. Aggressive HCC subtypes frequently exhibit Liver Imaging Reporting and Data System M features on magnetic resonance imaging, aiding in prognosis. A comprehensive understanding of tumor size, location, and biology is imperative for optimizing the benefits of local ablation therapy in managing HCCs.
引用
- Lee MW, Han S, Gu K, et al. Local Ablation Therapy for Hepatocellular Carcinoma: Clinical Significance of Tumor Size, Location, and Biology. Invest Radiol. 2024. PMID: 38970255. doi:10.1097/RLI.0000000000001100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。